US home › Medicare GLP-1 Bridge
The Medicare GLP-1 Bridge explained
About this page. Written by the GLPInfo editorial team with AI assistance from the official sources listed at the end, and approved by the site owner before publication. It has not been reviewed by a named clinician. Published 7 Sep 2026 · next scheduled review 7 Dec 2026.
This page is information, not medical advice. It never tells you which medicine or dose is right for you: those decisions sit with you and a licensed prescriber. Report suspected side effects to FDA MedWatch. Spotted an error? Tell us.
From 1 July 2026 to 31 December 2027, eligible Medicare members can obtain Wegovy, the Zepbound KwikPen or Foundayo for a flat $50 a month for weight management through participating pharmacies, outside their Part D benefit. It is the single largest price difference in the US market.
What it covers
Wegovy pens, Zepbound KwikPens and Foundayo tablets in 28-day or 30-day supplies, for weight-management use, at $50 a month. Amazon Pharmacy and Walmart list the program on their pages; eligibility criteria including BMI apply and are checked at enrolment.
What it is not
It is not Part D coverage of obesity medicines, which remains restricted; it is a bridge program that sits outside Part D until the end of 2027. It does not cover Ozempic or Mounjaro, which are diabetes brands with their own coverage rules, and it does not cover compounded products.
How it compares
Against the $299 to $449 self-pay floor for Zepbound and $349 for Wegovy, the Bridge is a saving of roughly $250 to $400 a month for those who qualify. If you are on Medicare, check eligibility before comparing anything else on this site.
Frequently asked questions
Who qualifies for the $50 Bridge price?
Medicare members meeting the program's eligibility criteria, which include weight-management criteria such as BMI, verified at enrolment by the participating pharmacy. Details are on Amazon Pharmacy's and Walmart's program pages.
Which pharmacies offer it?
Amazon Pharmacy and Walmart publish the program; others may participate. GLPInfo lists the program price under those channels.
When does it end?
The program runs to 31 December 2027 as published.